Clinical Cancer Genomics conference, March 20-21 2025, Amsterdam
We are pleased to announce that registration for this novel exciting meeting focused on cancer whole genome and transcriptome sequencing in a clinical setting, is now open. Please visit www.ccg2025.eu for more information, abstract submission or registration of your participation!
An increasing number of European countries are adapting clinical cancer (gen)omics programs including whole genome and transcriptome sequencing (WGTS) to enable cancer precision medicine and support research and a learning health care system for improving future cancer care.
This meeting will be the first of an annual recurring series and aims to bring together researchers and medical specialists involved in these programs or interested in genomics-based and data-driven cancer care and/or research. The current state-of-the-art implementations in routine care, research highlights, clinical impact and future developments will be presented and discussed.
National programs in Europe supporting translation of genomics approaches from the clinic to research and back will be central to this meeting. The first meeting will take place on Thursday March 20 and Friday 21, 2025 in Amsterdam, the Netherlands, and is initiated as part of the 10th anniversary of Hartwig Medical Foundation. The meeting will be organised together with Genomics England, DKFZ German Cancer Research Center MASTER/NCT, Genomic Medicine Sweden, Plan France Médecine Génomique 2025 , and Danish National Genome Center.
All news
Also read
Whole Genome Sequencing on Cerebrospinal Fluid: No Biopsy, Yet a Report
Whole genome sequencing is typically only performed on tissue biopsies. In collaboration with Hartwig Medical Foundation, a clinical molecular biologist …
Pay attention to the ethical aspects of data sharing
Frank van Wijck, science journalist Eline Bunnik is an associate professor at the Department of Medical Ethics, Philosophy and History of …
Nature publication: High resolution DNA-image of metastatic tumor provides new treatment insights
For the first time, Dutch researchers have created a detailed overview of the landscape of DNA-deviations in thousands of metastatic …
In our profession, we need to know everything about the patient, but we also want to know as much as possible about the patient’s tumor.